Eleven patients with intractable rheumatoid arthritis were treated with total lymphoid irradiation (total dose, 2000 rad) in an uncontrolled feasibility study, as an alternative to long-term therapy with cytotoxic drugs such as cyclophosphamide and azathioprine. During a follow-up period of five to 18 months after total lymphoid irradiation, there was a profound and sustained suppression of the absolute lymphocyte count and in vitro lymphocyte function, as well as an increase in the ratio of Leu-2 (suppressor/cytotoxic) to Leu-3 (helper) T cells in the blood. Persistent circulating suppressor cells of the mixed leukocyte response and of pokeweek mitogen-induced immunoglobulin secretion developed in most patients. In nine of the 11 patients, these changes in immune status were associated with relief of joint tenderness and swelling and with improvement in function scores. Maximum improvement occurred approximately six months after irradiation and continued for the remainder of the observation period. Few severe or chronic side effects were associated with the radiotherapy.
This article has been cited by other articles:
Jakus, Z., Simon, E., Frommhold, D., Sperandio, M., Mocsai, A.
(2009). Critical role of phospholipase C{gamma}2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis. JEM
206: 577-593
[Abstract][Full Text]
Chon, B. H., Loeffler, J. S.
(2002). The Effect of Nonmalignant Systemic Disease on Tolerance to Radiation Therapy. The Oncologist
7: 136-143
[Abstract][Full Text]
Ueki, Y., Yamasaki, S., Kanamoto, Y., Kawazu, T., Yano, M., Matsumoto, K., Miyake, S., Tominaga, Y., Iwamoto, U., Suemitsu, J., Matsuno, Y., Sizume, Y., Takenaka, Y., Eguchi, K.
(2000). Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology (Oxford)
39: 165-171
[Abstract][Full Text]
Paliard, X, West, S., Lafferty, J., Clements, JR, Kappler, J., Marrack, P, Kotzin, B.
(1991). Evidence for the effects of a superantigen in rheumatoid arthritis. Science
253: 325-329
[Abstract]
Varga, J., Haustein, U. F., Creech, R. H., Dwyer, J. P., Jimenez, S. A.
(1991). Exaggerated Radiation-Induced Fibrosis in Patients With Systemic Sclerosis. JAMA
265: 3292-3295
[Abstract]
BEN-CHETRIT, E., GROSS, D. J., BRAVERMAN, A., WESHLER, Z., FUKS, Z., SLAVIN, S., ELIAKIM, M.
(1986). Total Lymphoid Irradiation in Refractory Systemic Lupus Erythematosus. ANN INTERN MED
105: 58-60
[Abstract]
BARTON, J. C., PRASTHOFER, E. F., EGAN, M. L., HECK, L. W. Jr., KOOPMAN, W. J., GROSSI, C. E.
(1986). Rheumatoid Arthritis Associated with Expanded Populations of Granular Lymphocytes. ANN INTERN MED
104: 314-323
[Abstract]
ANDERSEN, P. A., WEST, S. G., O'DELL, J. R., VIA, C. S., CLAYPOOL, R. G., KOTZIN, B. L.
(1985). Weekly Pulse Methotrexate in Rheumatoid Arthritis: Clinical and Immunologic Effects in a Randomized, Double-Blind Study. ANN INTERN MED
103: 489-496
[Abstract]
STROBER, S., TANAY, A., FIELD, E., HOPPE, R. T., CALIN, A., ENGLEMAN, E. G., KOTZIN, B., BROWN, B. W., KAPLAN, H. S.
(1985). Efficacy of Total Lymphoid Irradiation in Intractable Rheumatoid Arthritis: A Double-Blind, Randomized Trial. ANN INTERN MED
102: 441-449
[Abstract]
STROBER, S., FIELD, E., HOPPE, R. T., KOTZIN, B. L., SHEMESH, O., ENGLEMAN, E., ROSS, J. C., MYERS, B. D.
(1985). Treatment of Intractable Lupus Nephritis with Total Lymphoid Irradiation. ANN INTERN MED
102: 450-458
[Abstract]
TRENTHAM, D. E., WEINBLATT, M. E., AUSTEN, K. F.
(1985). Total Lymphoid Irradiation in Tertiary Care for Rheumatoid Arthritis. ANN INTERN MED
102: 544-545
[Abstract]
DECKER, J. L., MALONE, D. G., HARAOUI, B., WAHL, S. M., SCHRIEBER, L., KLIPPEL, J. H., STEINBERG, A. D., WILDER, R. L.
(1984). Rheumatoid Arthritis: Evolving Concepts of Pathogenesis and Treatment. ANN INTERN MED
101: 810-824
[Abstract]
DECKER, J. L.
(1983). Apheresis and Rheumatoid Arthritis. ANN INTERN MED
98: 666-667
[Abstract]
McCarty, D. J., Carrera, G. F.
(1982). Intractable Rheumatoid Arthritis: Treatment With Combined Cyclophosphamide, Azathioprine, and Hydroxychloroquine. JAMA
248: 1718-1723
[Abstract]